Skip to main content
. 2023 Aug 9;10(8):ofad393. doi: 10.1093/ofid/ofad393

Table 4.

Complications and Outcomes of Patients With Community-Acquired Infective Endocarditis (IE), Healthcare-Associated IE, and Nosocomial IE

Complication/Outcome CIE
(n = 2854)
P Value HCIE
(n = 457)
P Value NIE
(n = 1209)
Complications
 Intracardiac complications 1016 (35.6) .15 147 (32.2) .33 411 (34.0)
 Vascular phenomena 287 (10.0) .15 36 (7.8) .13 71 (5.8)
 Heart failure 1195 (41.8) .20 177 (38.7) .13 518 (42.8)
 Persistent bacteremia 262 (9.1) <.01 60 (13.1) .05 206 (17.0)
 CNS involvement 649 (22.7) <.01 66 (14.4) .04 228 (18.8)
 Embolization 742 (25.9) <.01 92 (20.1) .92 241 (19.9)
 New murmur 1064 (37.2) .10 152 (33.2) .07 347 (28.7)
 Vegetation present 1957 (68.5) .08 332 (72.2) <.01 786 (65.0)
 Acute renal failure 1000 (35.0) .31 149 (32.6) <.01 509 (42.1)
 Septic shock 340 (11.9) .04 70 (15.3) .81 191 (15.8)
 Sepsis 478 (16.7) .04 94 (20.5) .89 245 (20.2)
Indication for surgery 2022 (70.8) .03 301 (65.9) <.01 880 (72.8)
Cardiac surgery 1484 (52.0) <.01 190 (41.6) .02 579 (47.9)
Indicated surgery not performed 567 (19.9) <.01 117 (25.6) .93 312 (25.8)
Duration of treatment, days, median (IQR) 39 (28–45) .53 38 (26–45) .31 41 (23–48)
Hospital stay, days, median (IQR) 34 (21–50) .11 36 (23–53) <.01 41 (24–58)
Mortality
 In-hospital 645 (22.6) <.01 148 (32.4) .40 418 (34.9)
 With surgery 274 (9.6) .29 51 (11.1) .60 146 (12.1)
 Without surgery 371 (12.9) <.01 97 (21.2) .60 272 (22.5)
 1-y mortality 779 (27.3) <.01 191 (41.8) .80 497 (41.2)
1-y recurrencea 35 (1.5) .10 9 (2.9) .04 9 (1.1)
Sequelae at dischargea 334 (15.1) .80 45 (14.5) .36 133 (16.8)

Data are presented as No. (%) unless otherwise indicated. Values in bold refer to results with statistically significant differences.

Abbreviations: CIE, community-acquired infective endocarditis; CNS, central nervous system; HCIE, healthcare-associated infective endocarditis; NIE, nosocomial infective endocarditis.

a

One-year recurrence and sequelae at discharge rates were calculated using surviving patients as the denominator (CIE, 2209; HCIE, 309; NIE, 791).